hematoxylin has been researched along with Cancer of Cervix in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.69) | 18.7374 |
1990's | 4 (15.38) | 18.2507 |
2000's | 6 (23.08) | 29.6817 |
2010's | 9 (34.62) | 24.3611 |
2020's | 5 (19.23) | 2.80 |
Authors | Studies |
---|---|
Kairu, J; Kalebi, AY; Muchiri, LW; Muvunyi, TZ; O'Connor, S; Ochuk, W; Rohner, E; Smith, JS; Waweru, W | 1 |
Bekkers, RLM; Bosgraaf, RP; Bulten, J; Ebisch, RMF; Heideman, DAM; Hermsen, M; Massuger, LFAG; Meijer, CJLM; Melchers, WJG; Rijstenberg, LL; Siebers, AG; Soltani, GG; van der Horst, J; van Kemenade, FJ; Vedder, JEM | 1 |
Fukagawa, Y; Imai, Y; Sugihara, S; Teranishi, T | 1 |
Chen, H; Chen, J; Fan, Z; Grzegorzek, M; Jiang, T; Li, C; Li, X; Liu, W; Sun, H; Wu, X; Zheng, Y | 1 |
Asvestas, P; Cavouras, D; Glotsos, D; Kalatzis, I; Konstantinou, C; Kostopoulos, S; Michail, G; Ravazoula, P; Sakellaropoulos, G | 1 |
Cavouras, D; Glotsos, D; Kalatzis, I; Konstandinou, C; Kostopoulos, S; Lavdas, E; Michail, G; Ravazoula, P; Sakellaropoulos, G | 1 |
Moya-Salazar, J; Rojas-Zumaran, V | 1 |
Chen, L; He, S; Ji, Y; Ji, ZG; Seng, J; Wang, GL; Wu, MH; Zhou, JM; Zhu, YY | 1 |
Chen, S; Fan, X; Kong, H; Liu, S; Ting Chin, C; Wang, T; Zhang, L | 1 |
Banerjee, P; Castellanos, MR; Davidov, A; Debata, PR; Fata, JE; Gomez, JP; Gundry, S; Maiman, M; Pirog, EC; Rajupet, S; Szerszen, A | 1 |
Buonocunto-Vázquez, G; Gurrola-Díaz, CM; Rosales-Quintana, S; Suárez-Rincón, AE; Vázquez-Camacho, G; von Knebel Doeberitz, M; Wentzensen, N | 1 |
Ballester, M; Bézu, C; Coutant, C; Daraï, E; Feron, JG; Rouzier, R; Uzan, S | 1 |
Adamkov, M; Bencat, M; Felcanová, D; Hybenová, J; Lauko, L; Moráveková, E; Rajcáni, J | 1 |
Bruchim, I; Elkeles, A; Fishman, A; Idelevich, P; Kristt, D; Okon, E; Rivkin, I; Terkieltaub, D | 1 |
Bao, H; Wu, Y | 1 |
Fu, CY; Gu, J; Gulam Razul, Ss; Lim, SK; Ng, BK | 1 |
DERAZHNE, AB | 1 |
GIARDINI, RG | 1 |
Akpolat, I; Chirala, M; Mody, DR; Ramzy, I; Smith, DA | 1 |
Binder, H; Braumann, UD; Einenkel, J; Horn, LC; Krafft, C; Salzer, R; Steller, W | 1 |
Arndal, SF; Bjelkenkrantz, K; Christiansen, P; Eck, M; Horn, LC; Lorey, T; Oster, A; Rassmussen, OF; Reichert, A; Ridder, R; Ruediger, T; Schmidt, D; Schneider, V; Skovlund, VR; Trunk, MJ | 1 |
Crum, CP; Lester, S; Resnick, M; Sheets, EE; Sparks, C; Tate, JE | 1 |
Coleman, RE; Goepel, J; Lorigan, PC; Radstone, DJ; Sheridan, E | 1 |
Bilgi, S; Breitenecker, G; Gitsch, G; Kaider, A; Kainz, C; Leodolter, S; Obermair, A; Reisenberger, K; Speiser, P; Wanner, C | 1 |
Birrer, MJ; Farley, J; Gray, K; Jakowlew, SB; Nycum, L; Prentice, M | 1 |
Auger, M; Colgan, TJ | 1 |
1 review(s) available for hematoxylin and Cancer of Cervix
Article | Year |
---|---|
Ultrastaging of lymph node in uterine cancers.
Topics: Endometrial Neoplasms; Eosine Yellowish-(YS); Female; Hematoxylin; Histocytological Preparation Techniques; Humans; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Staging; Staining and Labeling; Uterine Cervical Neoplasms; Uterine Neoplasms | 2010 |
25 other study(ies) available for hematoxylin and Cancer of Cervix
Article | Year |
---|---|
Utility of p16INK4a expression for the interpretation of uterine cervical biopsies in Kenya.
Topics: Adult; Aged; Biopsy; Colposcopy; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Kenya; Middle Aged; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2021 |
Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
Topics: Alphapapillomavirus; Biomarkers, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunohistochemistry; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2022 |
Reclassification of atypical immature metaplasia of the uterine cervix by combination of nuclear features on hematoxylin and eosin-stained sections without auxiliary immunohistochemistry.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Cervix Uteri; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunohistochemistry; Ki-67 Antigen; Metaplasia; Squamous Intraepithelial Lesions; Uterine Cervical Neoplasms | 2022 |
CAM-VT: A Weakly supervised cervical cancer nest image identification approach using conjugated attention mechanism and visual transformer.
Topics: Diagnosis, Computer-Assisted; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Image Processing, Computer-Assisted; Probability; Uterine Cervical Neoplasms | 2023 |
Assessment of HPV Risk Type in H&E-stained Biopsy Specimens of the Cervix by Microscopy Image Analysis.
Topics: Adolescent; Adult; Biopsy; Cervix Uteri; Clinical Decision-Making; Diagnostic Imaging; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Microscopy; Papillomaviridae; Papillomavirus Infections; Risk; Staining and Labeling; Uterine Cervical Neoplasms; Young Adult | 2020 |
Multifeature Quantification of Nuclear Properties from Images of H&E-Stained Biopsy Material for Investigating Changes in Nuclear Structure with Advancing CIN Grade.
Topics: Adolescent; Adult; Algorithms; Biopsy; Cell Nucleus; Coloring Agents; Computer Simulation; Contrast Media; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Image Processing, Computer-Assisted; Normal Distribution; Precancerous Conditions; Reproducibility of Results; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2018 |
Eco-Pap: The Ecological Modification of the Papanicolaou Stain for Sustainable Cervical Cancer Diagnosis.
Topics: Ammonia; Azo Compounds; Coloring Agents; Cross-Sectional Studies; Environmental Pollutants; Environmental Pollution; Female; Hematoxylin; Humans; Hydrochloric Acid; Medical Waste Disposal; Mercury Compounds; Oxides; Papanicolaou Test; Peru; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Staining and Labeling; Uterine Cervical Neoplasms; Vaginal Smears; Xylenes | 2019 |
Application of the CellDetect® staining technique in diagnosis of human cervical cancer.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Coloring Agents; Eosine Yellowish-(YS); Erythrocytes; Female; Hematoxylin; Humans; Papillomavirus Infections; Reagent Kits, Diagnostic; Sensitivity and Specificity; Staining and Labeling; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears | 2014 |
Automation-assisted cervical cancer screening in manual liquid-based cytology with hematoxylin and eosin staining.
Topics: Automation; Cell Nucleus; Cost-Benefit Analysis; Cytoplasm; Early Detection of Cancer; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Sensitivity and Specificity; Staining and Labeling; Uterine Cervical Neoplasms | 2014 |
Diagnostic imaging of cervical intraepithelial neoplasia based on hematoxylin and eosin fluorescence.
Topics: Algorithms; Coloring Agents; Cytodiagnosis; Diagnostic Imaging; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Image Interpretation, Computer-Assisted; Spectrometry, Fluorescence; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2015 |
P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
Topics: Adult; Biomarkers, Tumor; Conization; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunohistochemistry; Neoplasm Staging; Observer Variation; Reproducibility of Results; Staining and Labeling; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2008 |
[Detection of regulatory protein p16/INK4A in the dysplastic cervical squamous cell epithelium is a diagnostic tool for carcinoma prevention].
Topics: Biomarkers; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p16; DNA Probes, HPV; Epithelium; Female; Hematoxylin; Histocytochemistry; Humans; Precancerous Conditions; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2009 |
Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia.
Topics: Biopsy; Carcinoma, Squamous Cell; Coloring Agents; Eosine Yellowish-(YS); False Negative Reactions; Female; Hematoxylin; Humans; Israel; Neoplasm Staging; Observer Variation; Predictive Value of Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Staining and Labeling; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2010 |
p16INK4A and Ki-67 immunostaining on cell blocks from residual ThinPrep material is helpful in identifying significant preneoplastic cervical lesions.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cervix Uteri; Cyclin-Dependent Kinase Inhibitor p16; Cytological Techniques; Early Detection of Cancer; Eosine Yellowish-(YS); Feasibility Studies; Female; Hematoxylin; Humans; Immunohistochemistry; Ki-67 Antigen; Predictive Value of Tests; Sensitivity and Specificity; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears | 2011 |
Quantitative diagnosis of cervical neoplasia using fluorescence lifetime imaging on haematoxylin and eosin stained tissue sections.
Topics: Algorithms; Artificial Intelligence; Contrast Media; Eosine Yellowish-(YS); Evaluation Studies as Topic; Female; Fluorescent Dyes; Hematoxylin; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Microscopy, Fluorescence; Neoplasm Invasiveness; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Staining and Labeling; Uterine Cervical Neoplasms | 2014 |
[Intravital staining with hematoxylin in the clinical and histological diagnosis of the early stages of cancer of the cervix uteri. (Hemotoxylin test)].
Topics: Coloring Agents; Female; Hematoxylin; Humans; Neoplasms; Staining and Labeling; Uterine Cervical Neoplasms | 1960 |
[Cervical cancer; cytodiagnosis by means of smear with hematoxylin-eosin stain].
Topics: Cervix Uteri; Coloring Agents; Cytodiagnosis; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Neoplasms; Uterine Cervical Neoplasms | 1950 |
The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Feasibility Studies; Female; Hematoxylin; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Middle Aged; Papanicolaou Test; Specimen Handling; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears | 2004 |
Delimitation of squamous cell cervical carcinoma using infrared microspectroscopic imaging.
Topics: Carcinoma, Squamous Cell; Cluster Analysis; Eosine Yellowish-(YS); Epithelium; Female; Hematoxylin; Humans; Spectrophotometry, Infrared; Stromal Cells; Uterine Cervical Neoplasms | 2006 |
Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
Topics: Biomarkers, Tumor; Biopsy; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p16; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunohistochemistry; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Up-Regulation; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2008 |
Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
Topics: Antigens, Neoplasm; Antigens, Nuclear; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Coloring Agents; DNA, Viral; Female; Hematoxylin; Humans; Immunohistochemistry; In Situ Hybridization; Ki-67 Antigen; Neoplasm Proteins; Nuclear Proteins; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Retrospective Studies; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1996 |
Small cell carcinoma of the cervix.
Topics: Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cell Differentiation; Chromogranin A; Chromogranins; Coloring Agents; Combined Modality Therapy; Cytoplasmic Granules; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Treatment Failure; Treatment Outcome; Uterine Cervical Neoplasms | 1996 |
The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Endothelium, Vascular; Eosine Yellowish-(YS); Female; Follow-Up Studies; Hematoxylin; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Staining and Labeling; Uterine Cervical Neoplasms; von Willebrand Factor | 1998 |
Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Topics: Activin Receptors, Type I; Adenocarcinoma; Carcinoma in Situ; Cell Cycle Proteins; Cell Transformation, Neoplastic; Cervix Uteri; Cyclin-Dependent Kinase Inhibitor p27; Eosine Yellowish-(YS); Female; Genes, Tumor Suppressor; Hematoxylin; Humans; Immunohistochemistry; Ligands; Microtubule-Associated Proteins; Neoplasm Staging; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Staining and Labeling; Transforming Growth Factor beta; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2000 |
Detection of metastatic vulvar and cervical squamous carcinoma in regional lymph nodes by use of a polyclonal keratin antibody.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Immunoenzyme Techniques; Keratins; Lymph Nodes; Lymphatic Metastasis; Staining and Labeling; Uterine Cervical Neoplasms; Vaginal Smears; Vulvar Neoplasms | 1990 |